Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05325437 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients

Study acronym: ELSDL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 30, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Feb 28, 2025 to Jul 31, 2025v6
  2. Primary and study completion dates: Oct 1, 2024 to Feb 28, 2025v5
  3. Lead sponsor: Yangzhou University to Northern Jiangsu People's Hospitalv4
  4. 2 versions Re-verified since Jul 23, 2023, no change to tracked fieldsv2-v3
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, the investigators compared the improvement of liver reserve function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative liver reserve function and improve patient prognosis.
Trial Details
NCT Number NCT05325437
Lead Sponsor Northern Jiangsu People's Hospital
Conditions
(from sponsor)		 Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension
Related terms Fibrosis, Hypertension, Portal, Liver Cirrhosis
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov